Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells

Hypoxia commonly exists in solid tumors. In this adverse condition, adaptive responses including autophagy are usually provoked to promote cell survival. In our study, autophagy, a lysosomal-mediated degradation pathway, is demonstrated a protective way to make hepatocellular carcinoma cells be resi...

Full description

Saved in:
Bibliographic Details
Published inAutophagy Vol. 5; no. 8; pp. 1131 - 1144
Main Authors Song, Jianrui, Qu, Zengqiang, Guo, Xianling, Zhao, Qiudong, Zhao, Xue, Gao, Lu, Sun, Kai, Shen, Feng, Wu, Mengchao, Wei, Lixin
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 16.11.2009
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Hypoxia commonly exists in solid tumors. In this adverse condition, adaptive responses including autophagy are usually provoked to promote cell survival. In our study, autophagy, a lysosomal-mediated degradation pathway, is demonstrated a protective way to make hepatocellular carcinoma cells be resistant to chemotherapy under hypoxia. Compared with normoxia, chemotherapeutic agents-induced cell death under hypoxia was significantly decreased, as a result of the reduced apoptosis. However, when autophagy was inhibited by 3-MA or siRNA targeted Beclin 1, this reduction was reversed i.e. chemoresistance was attenuated, which means autophagy mediates the chemoresistance under hypoxia. In conclusion, autophagy decreases hepatoma cells sensitization to chemotherapeutic agents by affecting their apoptotic potential.
AbstractList Hypoxia commonly exists in solid tumors. In this adverse condition, adaptive responses including autophagy are usually provoked to promote cell survival. In our study, autophagy, a lysosomal-mediated degradation pathway, is demonstrated a protective way to make hepatocellular carcinoma cells be resistant to chemotherapy under hypoxia. Compared with normoxia, chemotherapeutic agents-induced cell death under hypoxia was significantly decreased, as a result of the reduced apoptosis. However, when autophagy was inhibited by 3-MA or siRNA targeted Beclin 1, this reduction was reversed i.e. chemoresistance was attenuated, which means autophagy mediates the chemoresistance under hypoxia. In conclusion, autophagy decreases hepatoma cells sensitization to chemotherapeutic agents by affecting their apoptotic potential.
Hypoxia commonly exists in solid tumors. Under such adverse conditions, adaptive responses including autophagy are usually provoked to promote cell survival. In our study, autophagy, a lysosomal-mediated degradation pathway, is demonstrated as a protective way to make hepatocellular carcinoma cells resistant to chemotherapy under hypoxia. Compared with normoxia, chemotherapeutic agent-induced cell death under hypoxia was significantly decreased, as a result of the reduced apoptosis. However, when autophagy was inhibited by 3-MA or siRNA targeted Beclin 1, this reduction was reversed, i.e., chemoresistance was attenuated, which means autophagy mediates the chemoresistance under hypoxia. In conclusion, autophagy decreases hepatoma cells sensitization to chemotherapeutic agents by affecting their apoptotic potential.Hypoxia commonly exists in solid tumors. Under such adverse conditions, adaptive responses including autophagy are usually provoked to promote cell survival. In our study, autophagy, a lysosomal-mediated degradation pathway, is demonstrated as a protective way to make hepatocellular carcinoma cells resistant to chemotherapy under hypoxia. Compared with normoxia, chemotherapeutic agent-induced cell death under hypoxia was significantly decreased, as a result of the reduced apoptosis. However, when autophagy was inhibited by 3-MA or siRNA targeted Beclin 1, this reduction was reversed, i.e., chemoresistance was attenuated, which means autophagy mediates the chemoresistance under hypoxia. In conclusion, autophagy decreases hepatoma cells sensitization to chemotherapeutic agents by affecting their apoptotic potential.
Hypoxia commonly exists in solid tumors. Under such adverse conditions, adaptive responses including autophagy are usually provoked to promote cell survival. In our study, autophagy, a lysosomal-mediated degradation pathway, is demonstrated as a protective way to make hepatocellular carcinoma cells resistant to chemotherapy under hypoxia. Compared with normoxia, chemotherapeutic agent-induced cell death under hypoxia was significantly decreased, as a result of the reduced apoptosis. However, when autophagy was inhibited by 3-MA or siRNA targeted Beclin 1, this reduction was reversed, i.e., chemoresistance was attenuated, which means autophagy mediates the chemoresistance under hypoxia. In conclusion, autophagy decreases hepatoma cells sensitization to chemotherapeutic agents by affecting their apoptotic potential.
Author Shen, Feng
Song, Jianrui
Guo, Xianling
Zhao, Xue
Gao, Lu
Qu, Zengqiang
Wu, Mengchao
Zhao, Qiudong
Sun, Kai
Wei, Lixin
Author_xml – sequence: 1
  givenname: Jianrui
  surname: Song
  fullname: Song, Jianrui
– sequence: 2
  givenname: Zengqiang
  surname: Qu
  fullname: Qu, Zengqiang
– sequence: 3
  givenname: Xianling
  surname: Guo
  fullname: Guo, Xianling
– sequence: 4
  givenname: Qiudong
  surname: Zhao
  fullname: Zhao, Qiudong
– sequence: 5
  givenname: Xue
  surname: Zhao
  fullname: Zhao, Xue
– sequence: 6
  givenname: Lu
  surname: Gao
  fullname: Gao, Lu
– sequence: 7
  givenname: Kai
  surname: Sun
  fullname: Sun, Kai
– sequence: 8
  givenname: Feng
  surname: Shen
  fullname: Shen, Feng
– sequence: 9
  givenname: Mengchao
  surname: Wu
  fullname: Wu, Mengchao
– sequence: 10
  givenname: Lixin
  surname: Wei
  fullname: Wei, Lixin
  email: lixinwei@smmu.edu.cn
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19786832$$D View this record in MEDLINE/PubMed
BookMark eNqFkU1v1DAQhi1URD_gyBXlxinbxE6c5FhVQJEq9UB7xZodj7tGiR1sR7D_HkfbLhICcfKHnndm9Mw5O3HeEWNv62rT1LK-hCX5TbvpN8MwyBfsrG7bpuylaE-Od96dsvMYv1WVkP3AX7HTeuh62Qt-xr7e7Gf_00JpnV6QdLHWm3fwuC_QuxTsdkkUi-SLtKMCdzT5QNHGBA6p8KbY0QzJI43jMkIoEAJa5yco1q_4mr00MEZ683ResIePH-6vb8rbu0-fr69uS2yFSCXpuuFVL2VFvEajkepegyQ-NKQrMAjYEefAq7ZD06DgldGkm22d39RKccHeH-rOwX9fKCY12bhOAI78ElUnsizZtUMm3z2Ry3YireZgJwh79awkA-UBwOBjDGR-I5ValatVkWpVr1blmRd_8GgTJLvaAzv-MyUPqTyhpri1PqKl7PTY7bgIBSFZHOk5ePmf4BfvHq8e7u_WXrM2OdEfEtYZHyb44cOoVYL96IMJeY82KvH3KX8BJ3rC3g
CitedBy_id crossref_primary_10_1111_j_1742_4658_2011_08381_x
crossref_primary_10_1016_j_canlet_2017_12_013
crossref_primary_10_1007_s12013_015_0558_z
crossref_primary_10_1016_j_canlet_2018_01_044
crossref_primary_10_1111_cpr_12411
crossref_primary_10_4028_www_scientific_net_AMR_926_930_1124
crossref_primary_10_3389_fonc_2021_738385
crossref_primary_10_18632_oncotarget_8433
crossref_primary_10_18632_oncotarget_9643
crossref_primary_10_1517_13543784_2014_912274
crossref_primary_10_1007_s00216_018_0996_8
crossref_primary_10_1038_s41388_017_0046_6
crossref_primary_10_1016_j_neo_2024_101015
crossref_primary_10_1016_j_ijpharm_2024_125156
crossref_primary_10_1186_s12863_022_01055_9
crossref_primary_10_3892_ijo_2018_4376
crossref_primary_10_18632_oncotarget_19048
crossref_primary_10_1111_1440_1681_12581
crossref_primary_10_3390_cancers14225685
crossref_primary_10_3390_cells1030597
crossref_primary_10_18632_oncotarget_2189
crossref_primary_10_1186_s10020_018_0033_6
crossref_primary_10_1128_MCB_00740_14
crossref_primary_10_1002_jcb_23274
crossref_primary_10_4161_auto_32229
crossref_primary_10_3892_ol_2017_6449
crossref_primary_10_12659_MSM_889486
crossref_primary_10_1002_jcp_26448
crossref_primary_10_1186_s12943_022_01620_x
crossref_primary_10_1016_j_phrs_2012_07_003
crossref_primary_10_1038_onc_2013_552
crossref_primary_10_1097_FJC_0000000000000295
crossref_primary_10_1039_D3NH00061C
crossref_primary_10_18632_aging_103027
crossref_primary_10_1371_journal_pone_0065304
crossref_primary_10_3892_ijo_2016_3557
crossref_primary_10_1186_1476_4598_10_12
crossref_primary_10_1016_j_jacbts_2020_04_014
crossref_primary_10_15252_embr_201438850
crossref_primary_10_1016_j_yexcr_2022_113334
crossref_primary_10_1016_j_yexmp_2010_11_011
crossref_primary_10_1038_s41388_018_0348_3
crossref_primary_10_1016_S0929_6646_10_60122_2
crossref_primary_10_18632_aging_202137
crossref_primary_10_1007_s00204_012_0931_2
crossref_primary_10_18632_oncotarget_17202
crossref_primary_10_1038_srep05382
crossref_primary_10_1155_2011_470597
crossref_primary_10_3109_15376516_2012_686534
crossref_primary_10_5507_bp_2015_025
crossref_primary_10_1016_j_jep_2017_07_020
crossref_primary_10_3389_fnut_2019_00148
crossref_primary_10_1371_journal_pone_0179357
crossref_primary_10_1016_j_canlet_2024_216856
crossref_primary_10_1038_s12276_022_00780_6
crossref_primary_10_1038_s41420_020_00315_w
crossref_primary_10_1016_j_biopha_2020_111023
crossref_primary_10_1038_s41598_017_09503_8
crossref_primary_10_1016_j_bcp_2011_06_015
crossref_primary_10_1016_j_biocel_2015_02_010
crossref_primary_10_1016_j_yexcr_2022_113105
crossref_primary_10_1016_j_semcancer_2014_06_001
crossref_primary_10_1007_s10549_015_3283_9
crossref_primary_10_1016_j_bbcan_2013_02_003
crossref_primary_10_1038_cddiscovery_2017_68
crossref_primary_10_3892_or_2015_3742
crossref_primary_10_1038_bcj_2014_96
crossref_primary_10_3892_ijo_2015_2885
crossref_primary_10_1038_s41598_022_12519_4
crossref_primary_10_1038_srep12291
crossref_primary_10_1186_s12929_019_0557_2
crossref_primary_10_18632_oncotarget_22890
crossref_primary_10_1016_j_abb_2020_108281
crossref_primary_10_3892_or_2013_2474
crossref_primary_10_1042_BSR20160238
crossref_primary_10_3390_ijms21238991
crossref_primary_10_1016_j_trsl_2017_11_007
crossref_primary_10_1111_febs_12810
crossref_primary_10_1016_j_molonc_2016_08_005
crossref_primary_10_3389_fonc_2018_00226
crossref_primary_10_3389_fonc_2022_1008902
crossref_primary_10_1074_jbc_M109_090530
crossref_primary_10_1158_0008_5472_CAN_11_1094
crossref_primary_10_3390_cancers9100137
crossref_primary_10_3724_SP_J_1008_2011_00238
crossref_primary_10_1016_j_canlet_2014_01_011
crossref_primary_10_1245_s10434_010_1444_y
crossref_primary_10_1007_s00280_018_3669_6
crossref_primary_10_1016_j_jbo_2016_03_001
crossref_primary_10_1080_15548627_2015_1034405
crossref_primary_10_3350_cmh_2020_0169
crossref_primary_10_1016_j_tranon_2020_100851
crossref_primary_10_1158_0008_5472_CAN_18_0491
crossref_primary_10_1186_2045_3701_4_49
crossref_primary_10_3109_15376516_2013_843105
crossref_primary_10_1016_j_canlet_2012_03_002
crossref_primary_10_1016_j_bcp_2013_01_022
crossref_primary_10_3892_ijmm_2016_2492
crossref_primary_10_1038_sj_bjc_6605904
crossref_primary_10_1007_s11626_021_00625_y
crossref_primary_10_1016_j_canlet_2011_09_034
crossref_primary_10_1038_cddis_2013_308
crossref_primary_10_1016_j_canlet_2020_11_045
crossref_primary_10_1016_j_ctrv_2011_06_010
crossref_primary_10_1158_1078_0432_CCR_12_1542
crossref_primary_10_1186_s12951_022_01385_x
crossref_primary_10_18632_oncotarget_20415
crossref_primary_10_18632_oncotarget_26637
crossref_primary_10_1080_15548627_2016_1164357
crossref_primary_10_1186_s13578_020_00494_0
crossref_primary_10_1186_s13046_020_01758_w
crossref_primary_10_3892_mmr_2015_4599
crossref_primary_10_1021_acsami_2c18267
crossref_primary_10_1016_j_bmcl_2020_127715
crossref_primary_10_3390_ijms20020300
crossref_primary_10_4254_wjh_v6_i10_752
crossref_primary_10_7717_peerj_14797
crossref_primary_10_4254_wjh_v13_i1_6
crossref_primary_10_1016_j_mrfmmm_2011_07_003
crossref_primary_10_1007_s00109_012_0966_0
crossref_primary_10_1038_cddis_2013_167
crossref_primary_10_1016_j_jep_2023_116633
crossref_primary_10_1148_radiol_2016152099
crossref_primary_10_3389_fphar_2022_968223
crossref_primary_10_3389_fonc_2022_891652
crossref_primary_10_1016_j_heliyon_2024_e29859
crossref_primary_10_1016_j_cellsig_2015_07_009
crossref_primary_10_1186_s12943_017_0734_4
crossref_primary_10_1038_s41392_020_00453_8
crossref_primary_10_3389_fonc_2021_783526
crossref_primary_10_1039_C9NJ05808G
crossref_primary_10_1007_s13273_020_00107_4
crossref_primary_10_1016_j_bbrc_2015_02_027
crossref_primary_10_1016_j_lfs_2020_118722
crossref_primary_10_1186_2045_3701_4_22
crossref_primary_10_1002_jcb_26912
crossref_primary_10_1002_pros_21337
crossref_primary_10_1016_j_exphem_2014_06_005
crossref_primary_10_1080_15548627_2019_1630223
crossref_primary_10_1016_j_cell_2017_07_008
crossref_primary_10_1038_onc_2016_521
ContentType Journal Article
Copyright Copyright © 2009 Landes Bioscience 2009
Copyright_xml – notice: Copyright © 2009 Landes Bioscience 2009
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.4161/auto.5.8.9996
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1554-8635
EndPage 1144
ExternalDocumentID 19786832
10_4161_auto_5_8_9996
10909996
Genre Research Article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
0BK
0R~
23N
30N
53G
5GY
AAJMT
AALDU
AAMIU
AAPUL
AAQRR
ABCCY
ABFIM
ABFMO
ABJNI
ABLIJ
ABPAQ
ABPEM
ABTAI
ABXUL
ABXYU
ACGFS
ACTIO
ADBBV
ADCVX
ADGTB
ADHGD
ADYSH
AEISY
AENEX
AEYOC
AFRVT
AGDLA
AHDZW
AIJEM
AIYEW
AKBVH
AKOOK
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AMPGV
AOIJS
AQRUH
AVBZW
AWYRJ
BAWUL
BLEHA
C1A
CCCUG
DGEBU
DIK
DKSSO
E3Z
EBS
EJD
F5P
GTTXZ
H13
HYE
KYCEM
M4Z
O9-
OK1
P2P
RNANH
ROSJB
RPM
RTWRZ
SNACF
TBQAZ
TDBHL
TEI
TFL
TFT
TFW
TQWBC
TR2
TTHFI
TUROJ
ZGOLN
-
0R
AAAVI
ABJVF
ABQHQ
AEGYZ
AFOLD
AHDLD
AIRXU
FUNRP
FVPDL
V1K
ZA5
AAGDL
AAHIA
AAYXX
CITATION
4.4
AAGME
ACDHJ
ACZPZ
ADOPC
AURDB
BFWEY
CGR
CUY
CVF
CWRZV
ECM
EIF
EMOBN
IPNFZ
LJTGL
NPM
PCLFJ
RIG
TASJS
7X8
ID FETCH-LOGICAL-c533t-ed14208660e21cfdce18da6e294ed0afcac7e22a2057cf4c320fded4b157ce563
ISSN 1554-8627
1554-8635
IngestDate Tue Aug 05 09:14:19 EDT 2025
Mon Jul 21 05:50:19 EDT 2025
Tue Jul 01 01:44:04 EDT 2025
Thu Apr 24 22:53:40 EDT 2025
Fri Jan 15 03:37:17 EST 2021
Tue May 21 11:32:54 EDT 2019
Tue May 20 10:46:39 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c533t-ed14208660e21cfdce18da6e294ed0afcac7e22a2057cf4c320fded4b157ce563
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.tandfonline.com/doi/pdf/10.4161/auto.5.8.9996?needAccess=true
PMID 19786832
PQID 734166759
PQPubID 23479
PageCount 14
ParticipantIDs pubmed_primary_19786832
landesbioscience_primary_autophagy_article_9996
informaworld_taylorfrancis_310_4161_auto_5_8_9996
proquest_miscellaneous_734166759
crossref_primary_10_4161_auto_5_8_9996
crossref_citationtrail_10_4161_auto_5_8_9996
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-11-16
PublicationDateYYYYMMDD 2009-11-16
PublicationDate_xml – month: 11
  year: 2009
  text: 2009-11-16
  day: 16
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Autophagy
PublicationTitleAlternate Autophagy
PublicationYear 2009
Publisher Taylor & Francis
Publisher_xml – name: Taylor & Francis
SSID ssj0036892
Score 2.36003
Snippet Hypoxia commonly exists in solid tumors. In this adverse condition, adaptive responses including autophagy are usually provoked to promote cell survival. In...
Hypoxia commonly exists in solid tumors. Under such adverse conditions, adaptive responses including autophagy are usually provoked to promote cell survival....
SourceID proquest
pubmed
crossref
landesbioscience
informaworld
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1131
SubjectTerms Adenine - analogs & derivatives
Adenine - pharmacology
Apoptosis - drug effects
Apoptosis Regulatory Proteins - metabolism
Autophagy - drug effects
Beclin-1
Binding
Biology
Bioscience
Calcium
Cancer
Carcinoma, Hepatocellular - pathology
Cell
Cell Cycle - drug effects
Cell Hypoxia - drug effects
Cisplatin - pharmacology
Cycle
Drug Resistance, Neoplasm - drug effects
Drug Screening Assays, Antitumor
Gene Knockdown Techniques
Green Fluorescent Proteins - metabolism
Hep G2 Cells
Humans
Landes
Liver Neoplasms - pathology
Membrane Proteins - metabolism
Organogenesis
Proteins
Title Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells
URI https://www.tandfonline.com/doi/abs/10.4161/auto.5.8.9996
http://www.landesbioscience.com/journals/autophagy/article/9996/
https://www.ncbi.nlm.nih.gov/pubmed/19786832
https://www.proquest.com/docview/734166759
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ri9NAEF_0RNAP5_O0vtgPIoKml0ezTT4eckeRs4fQQvGDy2Z3UgtnUq8JWP96Zzavtlzx8SW0082m2fnt7Mzs7Axjr700CAMtjDNE6wMNlEg7KqFEyMKNYuVCHBgyFD-NxWg6-DgLZ10xTnu6pEj6-te150r-h6tIQ77SKdl_4GzbKRLwM_IXr8hhvP4Vj0frZf5zoRy0q0vax1clpQlQ83UVgU6lrKoMDqRdIncoqHZFCiPNZqslLtHmJt-9DUbVVFcoy7-rd0RabeqtJ03PrUemCeWlhEHlovOf2t0OyOY_8Id5G91TWo_sDGmXi4785Zuy9M-L0uQ1ufFAxHQUrzog2QhNZHMkqrQjfbiGVkvacANQ0YbU9LxqJdgV52R80VqFr9gP-1GfjLNu3Wr26scX8mx6fi4np7PJTXbLR3uBBF7gjpslORCRrY7d_qkq2Sp1f7zV-ZZyspW69i67R5GmtGlXJxmF_TaJ1U0m99lhbVTwkwohD9gNyB6y21WZ0fUj9nUHJ7zFCd_ACS9yjjjhOzjhecq3ccJbnHCLk8dsenY6-TBy6roajkblvnDAeBRUIYQLvqdTo8GLjBLgxwMwrkq10kPwfeWjLq_TgQ58NzVgBomH3yEUwRE7yPIMnjIOAHoYCcrypwcQi8QkHgQx1ZZ3TQiix943Ayp1nXSeap9cSjQ-afwlvbEMZSRp_HvsTdt8WWVb2dfQ2-SOLKx7K61q0chgzz1vd1nYPoQmDYqOC2q7NGmPHe9t2rJI1vO-7pw3YJAooGn4VQZ5uZJD1BMFmuVxjz2pQNK9Woxjh0vqsz_f_Jzd6abeC3ZQXJXwEtXhInllof4b2nbA3g
linkProvider Taylor & Francis
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3JbtRAEC2FIAQcCDvD2gdAHLDjtW0fOCAgmpBkOJBIOaVpd5eTCLBH2CMYPolf4aeo8jKQoLkg5cDRVnvp6lpeucuvAB77RRiHRlonoeyDEpTUODpnImTppZn2MAstJ4o7Eznei97ux_sr8GP4F4bLKjmHLjqiiNZXs3Hzx2i2cMbj63rWVG7spi6j9b6gcgvnXyldq19svqa1fRIEG292X42dvqOAYwjWNA5an7eTpfQw8E1hDfqp1RKDLELr6cJok2AQ6IBQjCkiEwZeYdFGuU_HGMuQ7nsOzseZTNimQm8yeP1Qpm0DZg7PDmUJScfn-ffrnoh_J9hRL8MaFzPyvlDPY4nLYW8b_jbW4OcguK7q5aM7a3LXfD_FKfl_SPYqXOlRuHjZmc01WMHyOlzo-nLOb8DBeD6tvh1r57i0pPpW8AtPj_ThXLSl_dwjDGvRVILgsyC152rlmpE4SVNUhTiiIN9UvCnCVb7CcMOmsvqsBZ-qb8LemUzuFqyWVYl3QCCiSVLJtHgmwkzmNvcxzLgZu2djlCN4PqiHMj1LOzcL-aQoW-MlUjxjFatU8RKN4Oli-LSjJ1k20P9T11TTfg8quuYtKlxyzbPTCrl4yPuqPCQP-o7HTm0xgvWlQxdLpHpn2N9cDKqtyKOx-HWJ1axWCQErSXlsNoLbncr_nlpGsqMYdPcfZvMILo53d7bV9uZk6x5cancFuZxT3ofV5ssMHxC4bPKHrVUL-HDWyv4LTlKQWw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VIhAcKG-Wpw-AOJA0Tyc5cECU1ZbCggSVesI49qStgGRFsoLlH_FX-FXM5LHQor0g9cAxkePE488z38TjGYD7fhHGoZHWScj7IAclNY7OORGy9NJMe5iFlh3FV1M52Y1e7MV7a_BjOAvDYZXsQxddoohWV_PintmCFzjT8U09byo3dlOXyXofT7mDi6_krdVPtrdoah8Ewfj5u2cTpy8o4BhiNY2D1ufdZCk9DHxTWIN-arXEIIvQerow2iQYBDogEmOKyISBV1i0Ue7TNcYypH5PwWnJBzr5tIg3HZR-KNO2_jJbZ4echKRL5_n35x4xf0eSo56HDY5l5G2hPo0lrma9rfUbb8DPQW5d0MtHd97krvl-LKXkfyHYi3Ch5-DiabdoLsEalpfhTFeVc3EF3k8Ws-rboXYOS0vAt4I_eHag9xeiDeznCmFYi6YSRJ4FgZ5jlWvm4SRMURXigEx8U_GWCMf4CsPlmsrqsxZ8q74KuycyuGuwXlYl3gCBiCZJJSfFMxFmMre5j2HGpdg9G6McweMBHcr0Odq5VMgnRb4aT5HiEatYpYqnaAQPl81nXXKSVQ39P6GmmvZvUNGVblHhimceHcfj8iVvq3Kf9OdrbksAGsHmyqbLKVK9Kuw7FwOyFekzFr8usZrXKiFaJcmLzUZwvUP876FlJDuyQDf_YTT34OybrbF6uT3duQXn2i1BjuWUt2G9-TLHO8Qsm_xuu6YFfDhprP8C95mO_w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hypoxia-induced+autophagy+contributes+to+the+chemoresistance+of+hepatocellular+carcinoma+cells&rft.jtitle=Autophagy&rft.au=Song%2C+Jianrui&rft.au=Qu%2C+Zengqiang&rft.au=Guo%2C+Xianling&rft.au=Zhao%2C+Qiudong&rft.date=2009-11-16&rft.issn=1554-8635&rft.eissn=1554-8635&rft.volume=5&rft.issue=8&rft.spage=1131&rft_id=info:doi/10.4161%2Fauto.5.8.9996&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1554-8627&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1554-8627&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1554-8627&client=summon